Avanos Medical
AVNS
AVNS was delisted on the 24th of July, 2026.
272 hedge funds and large institutions have $1.23B invested in Avanos Medical in 2020 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 72 increasing their positions, 67 reducing their positions, and 50 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
7% more repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 67
0.4% less ownership
Funds ownership: 95.91% → 95.51% (-0.4%)
7% less funds holding
Funds holding: 293 → 272 (-21)
21% less capital invested
Capital invested by funds: $1.55B → $1.23B (-$324M)
34% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 50
50% less call options, than puts
Call options by funds: $1.21M | Put options by funds: $2.43M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CSC
Cove Street Capital
El Segundo,
California
|
+$16.6M |
| 2 |
CIM
Confluence Investment Management
St. Louis,
Missouri
|
+$14.9M |
| 3 |
PIM
Paradice Investment Management
Denver,
Colorado
|
+$10.5M |
| 4 |
Neuberger Berman Group
New York
|
+$8.47M |
| 5 |
Millennium Management
New York
|
+$6.61M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Group
London,
|
-$41.5M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$32.8M |
| 3 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
-$13.7M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$10M |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$8.08M |
AVNS Hedge Fund Activity: Q1 2020 in Review
272 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q1 2020, worth a combined $1.23B — down 21% from $1.55B a quarter earlier.
Sellers outnumbered buyers: 50 funds closed out of AVNS and 33 opened new positions — a net loss of 17 holders — while 67 trimmed existing stakes and 72 added.
The largest buyer was Cove Street Capital, adding an estimated $16.6M. The largest seller was Janus Henderson Group, exiting entirely with an estimated $41.5M sold.
- 272 institutional investors held Avanos Medical (AVNS) as of Q1 2020, down from 293 in Q4 2019.
- Funds reported $1.23B of Avanos Medical stock for Q1 2020, down 21% quarter-over-quarter.
- 33 funds opened new Avanos Medical positions in Q1 2020 and 50 closed out, a net change of -17 holders.
- The largest Avanos Medical buyer in Q1 2020 was Cove Street Capital, an estimated $16.6M added.
- The largest Avanos Medical seller in Q1 2020 was Janus Henderson Group, an estimated $41.5M sold.
Based on aggregated 13F filings for Q1 2020.